---
title: "United Therapeutics Corporation — Ownership Dossier"
canonical: https://whiteintel.dev/entity/abaace93-df59-4e6f-9785-eaada831a8f2
json: https://whiteintel.dev/api/public/dossier/abaace93-df59-4e6f-9785-eaada831a8f2
identifier: gb-coh:2638178
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# United Therapeutics Corporation

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:2638178`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/abaace93-df59-4e6f-9785-eaada831a8f2  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/abaace93-df59-4e6f-9785-eaada831a8f2  

## Ownership & control

### Holdings / subsidiaries

- **UNITED THERAPEUTICS EUROPE, LTD.** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/4fee63aa-9039-50e2-be9b-7acf660b5d7f

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **United Therapeutics Corporation**. Human view: https://whiteintel.dev/entity/abaace93-df59-4e6f-9785-eaada831a8f2 · Structured JSON: https://whiteintel.dev/api/public/dossier/abaace93-df59-4e6f-9785-eaada831a8f2._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._